A detailed history of Clayton Financial Group LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Clayton Financial Group LLC holds 1,448 shares of BSX stock, worth $148,695. This represents 0.07% of its overall portfolio holdings.

Number of Shares
1,448
Holding current value
$148,695
% of portfolio
0.07%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2025

Jan 21, 2026

BUY
$94.95 - $104.98 $137,487 - $152,011
1,448 New
1,448 $138 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $147B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Clayton Financial Group LLC Portfolio

Follow Clayton Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clayton Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clayton Financial Group LLC with notifications on news.